BioAdaptives Inc.
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Sep 2013 | $-749 | $-749 | — | $0 |
| Mar 2014 | $-7.1K | $-7.1K | — | — |
| Jun 2014 | $-19.5K | $-19.5K | — | $54.0K |
| Sep 2014 | $10.5K | $10.5K | — | — |
| Dec 2014 | $-42.5K | $-42.5K | — | — |
| Mar 2015 | $-363 | $-363 | — | $8.0K |
| Jun 2015 | $-796 | $-796 | — | $13.7K |
| Sep 2015 | $150 | $150 | — | $13.9K |
| Dec 2015 | $937 | $937 | — | — |
| Mar 2016 | $-1.7K | $-1.7K | — | $13.7K |
| Jun 2016 | $-209 | $-209 | — | $13.7K |
| Sep 2016 | $11.8K | $11.8K | — | $13.9K |
| Mar 2019 | $-46.9K | $-46.9K | — | $21.0K |
| Jun 2019 | $-12.5K | $-12.5K | — | $21.0K |
| Sep 2019 | $-32.4K | $-32.4K | — | $23.2K |
| Dec 2019 | $-76.4K | $-76.4K | — | $-65.2K |
| Mar 2020 | $-42.3K | $-42.3K | — | $47.1K |
| Jun 2020 | $-20.2K | $-20.2K | — | $46.3K |
| Sep 2020 | $-34.5K | $-34.5K | — | $-46.3K |
| Dec 2020 | $-9.9K | $-9.9K | — | $0 |
| Mar 2021 | $-60.4K | $-60.4K | — | $163.9K |
| Jun 2021 | $-29.7K | $-29.7K | — | $0 |
| Sep 2021 | $-33.2K | $-33.2K | — | $0 |
| Dec 2021 | $-35.4K | $-35.4K | — | $0 |
| Mar 2022 | $-61.2K | $-61.2K | — | — |
| Jun 2022 | $-77.1K | $-77.1K | — | $0 |
| Sep 2022 | $-61.5K | $-61.5K | — | $0 |
| Dec 2022 | $-27.5K | $-27.5K | — | — |
| Mar 2023 | $-19.5K | $-19.5K | — | — |
| Jun 2023 | $-56.9K | $-56.9K | — | — |
| Sep 2023 | $-56.1K | $-56.1K | — | — |
| Dec 2023 | $-91.3K | $-91.3K | — | — |
| Mar 2024 | $-41.2K | $-41.2K | — | — |
| Jun 2024 | $-51.5K | $-51.5K | — | — |
| Sep 2024 | $-56.3K | $-56.3K | — | — |
| Dec 2024 | $-100.5K | $-100.5K | — | — |
| Mar 2025 | $-97.9K | $-97.9K | — | — |
| Jun 2025 | $-111.0K | $-111.0K | — | $28.7K |
| Sep 2025 | $-151.3K | $-151.3K | — | — |
| Dec 2025 | $-155.8K | $-155.8K | — | — |
| Mar 2026 | $-84.8K | $-84.8K | — | — |
| Jun 2026 | $-44.4K | $-44.4K | — | — |